Fatigue in multiple sclerosis;Fatigue bei multipler sklerose

Neurologie und Rehabilitation

Volumn 9, Issue 6, 2003, Pages 263-271

  Engel, C ^a   Greim, B ^a   Zettl, U K ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Diagnosis; Fatigue; Multiple sclerosis; Therapy

Indexed keywords

4 AMINOPYRIDINE; ADEKIN; AMAN; AMANTA; AMANTADIN AL; AMANTADIN NEURAXPHARM; AMANTADIN RATIOPHARM; AMANTADINE; AVONE; BETA1A INTERFERON; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MODAFINIL; PAROXETINE; PEMOLINE; PROKARIN; SENIOR 20; SERTRALINE;

BEHAVIOR THERAPY; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; PATHOGENESIS; PHYSIOTHERAPY; REVIEW; SYMPTOMATOLOGY;

EID: 0347285480     PISSN: 09472177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Appenzeller O: The autonomic nervous system and fatigue. Funct Neurol 1987; 2: 473-485
2. Bakshi R, Miletich RS, Henschel K, Shaikh ZA, Janardhan V, Wasay M, et al.: Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology 1999; 53: 1151-1153
3. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, et al.: Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000; 6: 181-185
4. Belza BL, Henke CJ, Yelin EH, Epstein WV, Gilliss CL: Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 1993; 42: 93-99
5. Brasil-Neto JP, Cohen LG, Hallett M: Central fatigue as revealed by postexercise decrement of motor evoked potentials. Muscle Nerve 1994; 17: 713-719
6. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al.: Development of a fatigue scale. J Psychosom Res 1993; 37: 147-153
7. Cohen RA, Fisher M: Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 1989; 46: 676-680
8. Colombo B, Martinelli-Boneschi F, Rossi P, Rovaris M, Maderna L, Filippi M, et al.: MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 2000; 247: 506-509
9. Colosimo C, Millefiorini EM, Vinci F, Fiorelli M, Koudriavtseva T, Pozzilli C: Fatigue in MS is associated with specific clinical features. Acta Neurol Scand 1995; 92: 353-355
10. de Haan A, de Ruiter CJ, van der Woude LH, Jongen PJ: Contractile properties and fatigue of quadriceps muscles in multiple sclerosis. Muscle Nerve 2000; 23: 1534-1541
11. Deale A, Chalder T, Marks I, Wessely S: Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry 1997; 154: 408-414
12. Di Fabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT: Extended outpatient rehabilitation: its influence on symptom frequency, fatigue and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998; 79: 141-146
13. Dickinson CJ: Chronic fatigue syndrom - aetiological aspects. Eur J Clin Invest 1997; 27: 257-267
14. Djaldetti R, Ziv I, Achiron A, Melamed E: Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment. Neurology 1996; 46: 632-635
15. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, et al.: Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002; 15: 559-567
16. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ: The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21: 9-14
17. Flachenecker P, Kumpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann, P, et al.: Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523-526
18. Flensner G, Lindencrona C: The cooling-suit: case studies of its influence on fatigue among eight individuals with multiple sclerosis. J Adv Nurs 2002; 37: 541-550
19. Ford H, Trigwell P, Johnson M: The nature of fatigue in multiple sclerosis. J Psychosom Res 1998; 45: 33-38.
20. Gillson G, Richard TL, Smith RB, Wright JV: A double-blind pilot study of the effect of Prokarin on fatigue in multiple sclerosis. Mult Scler 2002; 8: 30-35
21. Greim B, Benecke R, Zettl UK, Rückert S, Respondek E: Fatigue testing in multiple sclerosis (MS). Mult Scler 2001; Suppl 1: S27
22. Haupts M, Calabrese P, Greim B, Zettl UK: Neuropsychologische Befunde und Therapieoptionen bei Multipler Sklerose. In: Zettl UK, Mix E (eds): Multiple Sklerose: Kausalorientierte, symptomatische und rehabilitative Therapie. Springer, Berlin 2001, 251-270
23. Hoffmann F: Symptomatische Therapie. In: Schmidt RM, Hoffmann F (eds): Multiple Sklerose. Urban & Fischer, München 2002, 184-236
24. Iriarte J, De Castro P: Correlation between symptom fatigue and muscular fatigue in multiple sclerosis. Eur J Neurol 1998; 5: 579-585
25. Iriarte J, Katsamakis G, De Castro P: The fatigue descriptive scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler 1999; 5: 10-16
26. Iriarte J, Subirá ML, De Castro P: Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Mult Scler 2000; 6: 124-130
27. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, et al.: Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996; 39: 285-294
28. Johnson SK, Lange G, DeLuca J, Korn LR, Natelson B: The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, multiple sclerosis and depression. Appl Neuropsychol 1997; 4: 145-153
29. Kroencke DC, Lynch SG, Denney DR: Fatigue in multiple sclerosis: relationship to depression, disability and disease pattern. Mult Scler 2000; 6: 131-136
30. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC: Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435-437
31. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, et al.: Fatigue therapy in multiple sclerosis: Results of a double-blind, randomized, parallel trial of amantadine, pemoline and placebo. Neurology 1995; 45: 1956-1961
32. Krupp LB, Elkins LE: Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000; 55: 934-939
33. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD: The Fatigue Severity Scale. Application to patients with multiple sclerosis and systematic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123
34. Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P, et al.: Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement - EEG evidence. Neuroimage 2001; 13: 1186-1192
35. Mainero C, Faroni J, Gasperini C, Filippi M, Giugni E, Ciccarelli O, et al.: Fatigue and magnetic resonance imaging activity in multiple sclerosis. J Neurol 1999; 246: 454-458
36. Metz LM, Patten SB, Rose SM, McGuinness SD, Harris CJ, Bakker JI, et al.: Multiple sclerosis fatigue is decreased at 6 months by glatiramer acetate (Copaxone). J Neurol 2001; 248: II 115
37. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A: Correlates of cognitive impairment and depressive disorder in multiple sclerosis. Acta Psychiatr Scan 1994; 89: 117-121
38. Mostert S, Kesselring J: Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 2002; 8: 161-168
39. Multiple Sclerosis Council for Clinical Practice Guidelines: Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America, Washington DC 1998
40. Naschitz JE, Rosner I, Rozenbaum M, Naschitz S, Musafia-Priselac R, Shaviv N, et al.: The head-up tilt test with haemodynamic instability score in diagnosing chronic fatigue syndrome. QJM 2003; 96: 133-142
41. Neilly LK, Goodin DS, Goodkin DE, Hauser SL: Side effects profile of interferon beta-1b in MS. Neurology 1996; 46: 552-554
42. Oligiati R, Burgunder J-M, Mumenthaler M: Increased energy cost of walking in multiple sclerosis: Effect of spasticity, ataxia and weakness. Arch Phys Med Rehabil 1988; 69: 846-849
43. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW, et al.: Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996; 39: 432-441
44. Polman CH, Bertelsmann FW, van Loenen AC, Koetsier JC: 4-Aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety. Arch Neurol 1994; 51: 292-296
45. PRISMS Study Group: Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 1998; 352: 1498-1504
46. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN: Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72: 179-183
47. Rice CL, Volmer TL, Bigland-Ritchie B: Neuromuscular responses of patients wuth multiple sclerosis. Muscle Nerve 1992; 15: 1123-1132.
48. Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, et al.: Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A F-fluorodeoxyglucose positron emission tomography study. Neurology 1997; 48: 1566-1571
49. Rolak LA: Fatigue and multiple sclerosis. In: Dawson DM, Sabin TD (eds): Chronic fatigue syndrom. Little, Brown and Company, Boston 1993, 153-160
50. Rossini PM, Pasqualetti P, Pozzilli C, Grasso MG, Millefiorini E, Graceffa A, et al.: Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 2001; 7: 354-358
51. Sandroni P, Walker C, Starr A: Fatigue in patients with multiple sclerosis. Motor pathways conduction and event-related potentials. Arch Neurol 1992; 49: 517-524
52. Schäfer ML: Zur Geschichte des Neurastheniekonzeptes und seiner modernen Varianten Chronic-Fatigue-Syndrom, Fibromyalgie sowie Multiple Chemische Sensitivität. Fortschr Neurol Psychiat 2002; 70: 570-582
53. Schreurs K, de Ridder D, Bensing J: Fatigue in multiple sclerosis: Reciprocal relationships with physical disabilities and depression. J Psychosom Res 2002; 53: 775-781
54. Schwartz CE, Coulthard-Morris L, Zeng Q: Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 1996; 77: 165-170
55. Schwartz JE, Jandorf L, Krupp LB: The measurement of fatigue: a new instrument. J Psychosom Res 1993; 37: 753-762
56. Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD: Quantitative assessment of motor-fatigue and strength in MS. Neurology 1999; 53: 743-750
57. Scott PJ, Huskisson EC: Measurement of functional capacity with visual analogue scales. Rheumatol Rehabil 1977; 16: 257-259
58. Sheean GL, Murray NM, Rothwell JC, Miller A, Thompson AJ: An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. Brain 1998; 121: 967-975
59. Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ: An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 1997; 120: 299-315
60. Smets EM, Garssen B, Bonke B, de Haes JC: The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315-325
61. Svensson B, Gerdle B, Elert J: Endurance training in aptients with multiple sclerosis: five case studies. Phys Ther 1994; 74: 1017-1026
62. The IFNB Multiple Sclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43: 655-661
63. The Multiple Sclerosis Association of America: Multiple Sclerosis and Cooling. MSAA, Cherry Hill, New Jersey 2001
64. Van der Werf SP, Jongen PJ, Lycklama á Nijeholt GJ, Barkhof F, Hommes OR, Bleijenberg G: Fatigue in multiple sclerosis: Interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. J Neurol Sci 1998; 160: 164-170
65. Vercoulen JH, Hommes OR, Swanink CM, Jongen PJ, Fennis JF, Galama JM, et al.: The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrom and healthy subjects. Arch Neurol 1996; 53: 642-649
66. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G: Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38: 383-392
67. Vercoulen JH, Swanink CM, Galama JM, Fennis JF, Jongen PJ, Hommes OR, et al.: The persistance of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998; 45: 507-517
68. Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GP: A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992; 42: 1468-1471
69. Wessely S: Old wine in new bottles. Neurasthenia and "ME". Psychol Med 1990; 20: 35-53
70. White P: Fatigue syndrome: neurasthenia revived. Br Med J 1989; 298: 1199-1200
71. Zifko UA, Rupp M, Schwarz S, Zipko HA, Maida EM: Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 2002; 249: 983-987
72. Zimmermann C, Hohlfeld R: »Fatigue« bei multipler Sklerose. Nervenarzt 1999; 70: 566-574
73. Zimmermann P, Fimm B: Testbatterie zur Aufmerksamkeitsprüfung (TAP). Psytest, Würselen 1995